Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea Hrušková
Observed names:
A. Hrušková,
Andrea Hruskova,
Hruskova, Andrea
Observed institutions:
University Hospital Olomouc,
Palacký University Olomouc
OpenAlex ID:
A5090401378
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
2022
·
Ales Obr
, Katerina Benesova
, et al.
·
Annals of Hematology
·
5
PDF
Optimizing risk stratification in patients aged 80+ years with large B-cell lymphoma: Comparison of prognostic indices in three pooled international cohorts
2025
·
Prokop Vodicka
, Yucai Wang
, et al.
·
Blood
·
1
Targeted treatment approaches for mantle cell lymphoma
2026
·
Andrea Hrušková
, Pavel Klener
, et al.
·
Transfuze a hematologie dnes
Early isolated central nervous system relapse of mantle cell lymphoma successfully treated with ibrutinib and CAR T-cell therapy
2025
·
Andrea Hrušková
, Romana Szotkowska
, et al.
·
Transfuze a hematologie dnes
Comparable PFS in isolated parenchymal cns vs systemic relapse of DLBCL: Results from a large real-world cohort
2025
·
Michal Masar
, Prokop Vodicka
, et al.
·
Blood
PDF
Fundamental prognostic difference of ATM gene mutation and deletion in newly diagnosed mantle cell lymphoma
2025
·
Ales Obr
, Diana Malarikova
, et al.
·
Molecular Medicine
PDF
The Survival Improvement of Transplant-Eligible Primary CNS Lymphoma Patients within Last 15 Years
2024
·
Prokop Vodicka
, Katerina Benesova
, et al.
·
Blood
PDF
Type of Atm Aberration Has a Different Impact on Survival Parameters in Mantle Cell Lymphoma
2023
·
A. Obr
, D. Maláriková
, et al.
·
Hematological Oncology
PDF
Show more works
View as search
Works count:
10
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type
